Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients

Clinical Nephrology

Volumn 55, Issue 4, 2001, Pages 313-317

  De Vecchi, A F ^a   Bamonti Catena, F ^a   Finazzi, S ^a   Patrosso, C ^a   Taioli, E ^a   Novembrino, C ^a   Colucci, P ^a   Lando, G ^a   De Franceschi, M ^a   Marocchi, A ^a   Maiolo, A T ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Erythrocyte folate; Hemodialysis; Homocysteine; Peritoneal dialysis; Serum folate; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANEMIA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ERYTHROCYTE LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; GENDER; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PERITONEAL DIALYSIS; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGED; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PERITONEAL DIALYSIS; VITAMIN B 12;

EID: 0035057330     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
2. The effect of glomerular filtration rate on plasma total homocysteine concentration
3. Folate measurements in patients on regular hemodialysis treatment
4. Whole blood folate concentrations: Comparison between Stratus Folate (DADE) and radioassay (DPC) methods
5. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
6. Interaction between homocysteine and nutritional status of hemodialysis patients
7. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients
8. Plasma homocysteine (Hcy) after folate supplementation in PD patients (pts) with normal erythrocyte folate (ery-F)
9. Homocysteinemia and vascular disease in end-stage renal disease
10. What is subjective global assessment of nutritional status?
11. Plasma homocysteine levels are significantly higher in underweight patients on HD than in normal or overweight patients
12. Mutation (677C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
13. A candidate risk for vascular disease: A common mutation in methylentetrahydrofolate reductase
14. Protein bound homocysteine in normal subjects and in patients with homocystinuria
15. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients
16. Major determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis patients
17. Metabolic consequences of folate induced reduction of hyperhomocyst(e)inemia in uremia
18. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography mass spectrometry
19. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy
20. Major determinants of homocysteinemia in peritoneal dialysis patients
21. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis
22. Homocysteine and atherothrombosis
23. Effect of withdrawal of folic acid supplementation in maintenance hemodialysis patients